Dimopoulos, M., Weisel, K., Moreau, P., Anderson, L. D., White, D., San-Miguel, J., . . . Richardson, P. (2020). Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): Outcomes by prior treatment at first relapse. Leukemia.
Chicago Style CitationDimopoulos, Meletios, et al. "Pomalidomide, Bortezomib, and Dexamethasone for Multiple Myeloma Previously Treated With Lenalidomide (OPTIMISMM): Outcomes By Prior Treatment At First Relapse." Leukemia 2020.
Cita MLADimopoulos, Meletios, et al. "Pomalidomide, Bortezomib, and Dexamethasone for Multiple Myeloma Previously Treated With Lenalidomide (OPTIMISMM): Outcomes By Prior Treatment At First Relapse." Leukemia 2020.
Atenció: Aquestes cites poden no estar 100% correctes.